Business Description
Pharnext SA
ISIN : FR001400N1P4
Compare
Compare
Traded in other countries / regions
ALPHA.FranceP0X.GermanyPNEXF.USA IPO Date
2016-07-18Description
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -8.14 | |||||
Debt-to-Equity | -0.77 | |||||
Debt-to-EBITDA | -1.03 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -35.38 | |||||
Beneish M-Score | -33.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -82.5 | |||||
3-Year EBITDA Growth Rate | 68.7 | |||||
3-Year Book Growth Rate | 64.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 6.46 | |||||
9-Day RSI | 10.49 | |||||
14-Day RSI | 24.04 | |||||
6-1 Month Momentum % | -98.93 | |||||
12-1 Month Momentum % | -100 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.41 | |||||
Quick Ratio | 0.41 | |||||
Days Sales Outstanding | 1551.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -290.7 | |||||
Shareholder Yield % | -8895.83 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -238870 | |||||
Net Margin % | -275180 | |||||
FCF Margin % | -239130 | |||||
ROA % | -522.79 | |||||
ROIC % | -1677.66 | |||||
ROC (Joel Greenblatt) % | -9461.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.02 | |||||
EV-to-EBITDA | -1.03 | |||||
EV-to-Forward-EBITDA | -2.07 | |||||
EV-to-Revenue | 2617.2 | |||||
EV-to-Forward-Revenue | 2.79 | |||||
EV-to-FCF | -1.09 | |||||
Earnings Yield (Greenblatt) % | -98.07 | |||||
FCF Yield % | -140664.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharnext SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.01 | ||
EPS (TTM) (€) | -5000085.495 | ||
Beta | 0 | ||
Volatility % | 163.87 | ||
14-Day RSI | 24.04 | ||
14-Day ATR (€) | 0.006753 | ||
20-Day SMA (€) | 0.0081 | ||
12-1 Month Momentum % | -100 | ||
52-Week Range (€) | 0.001 - 125000 | ||
Shares Outstanding (Mil) | 13.21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharnext SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharnext SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Pharnext SA Frequently Asked Questions
What is Pharnext SA(XPAR:ALPHA)'s stock price today?
The current price of XPAR:ALPHA is €0.00. The 52 week high of XPAR:ALPHA is €125000.00 and 52 week low is €0.00.
When is next earnings date of Pharnext SA(XPAR:ALPHA)?
The next earnings date of Pharnext SA(XPAR:ALPHA) is .
Does Pharnext SA(XPAR:ALPHA) pay dividends? If so, how much?
Pharnext SA(XPAR:ALPHA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |